Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...

DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable ...

In a visit to UB, the lawmakers said cutting indirect cost reimbursement for grants would negatively impact livesaving ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

N.Y., decried the cuts as illegal and rooted in a willful misunderstanding of how medical research is conducted at ...

The University Professional and Technical Employees CWA Local 9119, representing approximately 20,000 UC healthcare, research ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Keynote Presentation. Dr. William Dahut discussed how ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

The rapid evolution of diabetes research and management calls for a forward-thinking approach that embraces innovation to address the multifaceted ...